1. Home
  2. PSTX vs PCYO Comparison

PSTX vs PCYO Comparison

Compare PSTX & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTX
  • PCYO
  • Stock Information
  • Founded
  • PSTX 2014
  • PCYO 1976
  • Country
  • PSTX United States
  • PCYO United States
  • Employees
  • PSTX N/A
  • PCYO N/A
  • Industry
  • PSTX Biotechnology: Biological Products (No Diagnostic Substances)
  • PCYO Water Supply
  • Sector
  • PSTX Health Care
  • PCYO Utilities
  • Exchange
  • PSTX Nasdaq
  • PCYO Nasdaq
  • Market Cap
  • PSTX 360.4M
  • PCYO 315.4M
  • IPO Year
  • PSTX 2020
  • PCYO N/A
  • Fundamental
  • Price
  • PSTX $2.71
  • PCYO $13.80
  • Analyst Decision
  • PSTX Strong Buy
  • PCYO
  • Analyst Count
  • PSTX 2
  • PCYO 0
  • Target Price
  • PSTX $15.00
  • PCYO N/A
  • AVG Volume (30 Days)
  • PSTX 557.2K
  • PCYO 46.3K
  • Earning Date
  • PSTX 11-07-2024
  • PCYO 11-13-2024
  • Dividend Yield
  • PSTX N/A
  • PCYO N/A
  • EPS Growth
  • PSTX N/A
  • PCYO 152.63
  • EPS
  • PSTX N/A
  • PCYO 0.48
  • Revenue
  • PSTX $150,858,000.00
  • PCYO $28,747,000.00
  • Revenue This Year
  • PSTX $64.38
  • PCYO N/A
  • Revenue Next Year
  • PSTX N/A
  • PCYO N/A
  • P/E Ratio
  • PSTX N/A
  • PCYO $27.29
  • Revenue Growth
  • PSTX 203.18
  • PCYO 97.09
  • 52 Week Low
  • PSTX $1.87
  • PCYO $8.94
  • 52 Week High
  • PSTX $4.27
  • PCYO $13.70
  • Technical
  • Relative Strength Index (RSI)
  • PSTX 46.81
  • PCYO 75.01
  • Support Level
  • PSTX $2.63
  • PCYO $12.72
  • Resistance Level
  • PSTX $2.82
  • PCYO $13.48
  • Average True Range (ATR)
  • PSTX 0.33
  • PCYO 0.58
  • MACD
  • PSTX -0.03
  • PCYO 0.18
  • Stochastic Oscillator
  • PSTX 19.86
  • PCYO 100.00

About PSTX Poseida Therapeutics Inc.

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: